Using highly variable warfarin dosing to identify patients at risk for adverse events
<p>Abstract</p> <p>Background</p> <p>Patients who receive highly variable doses of warfarin may be at risk for poor anticoagulation control and adverse events. However, we lack a system to identify patients with the highest dose variability. Our objectives were to devel...
Main Authors: | Henault Lori E, Ozonoff Al, Evans Mary, Marrast Lyndonna, Rose Adam J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://www.thrombosisjournal.com/content/9/1/14 |
Similar Items
-
Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
by: Salih Kilic, et al.
Published: (2018-01-01) -
Weekly missing dose (“6/7” SSU Protocol): A rational approach in warfarin use
by: Sina Owlia
Published: (2015-01-01) -
Warfarin Toxicity and Individual Variability—Clinical Case
by: Steven Boyages, et al.
Published: (2010-10-01) -
Enzyme polymorphism in warfarin dose management after pediatric cardiac surgery
by: Avisa Tabib, et al.
Published: (2015-01-01) -
Beyond warfarin: The advent of new oral anticoagulants
by: Sandeep T Laroia, et al.
Published: (2015-10-01)